KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.

  • Pfizer's Long-Term Investments fell 8014.31% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 8014.31%. This contributed to the annual value of $2.2 billion for FY2024, which is 8550.23% down from last year.
  • According to the latest figures from Q3 2025, Pfizer's Long-Term Investments is $2.1 billion, which was down 8014.31% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Long-Term Investments peaked at $21.6 billion during Q4 2021, and registered a low of $2.0 billion during Q1 2025.
  • Its 5-year average for Long-Term Investments is $13.2 billion, with a median of $14.2 billion in 2023.
  • As far as peak fluctuations go, Pfizer's Long-Term Investments surged by 4198.08% in 2023, and later tumbled by 8550.23% in 2024.
  • Over the past 5 years, Pfizer's Long-Term Investments (Quarter) stood at $21.5 billion in 2021, then tumbled by 49.72% to $10.8 billion in 2022, then skyrocketed by 41.98% to $15.4 billion in 2023, then crashed by 85.5% to $2.2 billion in 2024, then fell by 4.08% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, $2.1 billion for Q2 2025, and $2.0 billion during Q1 2025.